PapersPMID:34664527

The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology2022The record ↗

01 · finding: 1
02 · compound: 1
03 · endpoint: 1
04 · null: 0

coenzyme Q10

PMID:34664527 · 1 finding from this paper, in bands by direction at evidence strength

What it reported

How to read these marks

What moved

1 finding

coenzyme Q10 — decreases C-reactive protein concentration
Evidence strength: very limited.Findingreplicated ×3
“The supplementation of CoQ10 decreased significantly the scores of Beck Depression Inventory (BDI) (p = .03) and Beck Anxiety Inventory (BAI) (p = .01) and high-sensitivity C-reactive protein (hs-CRP) level (p = .005) when comparing with the placebo group.”
Quoted verbatim from The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome..
Study

RCT
Duration

3 months
Dose

100 mg/day CoQ10, 12 weeks
Population

Women with polycystic ovary syndrome (PCOS), aged 18-40 years
The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.2022PMID:3466452710.1080/09513590.2021.1991910Permalink

Study record

Read under: coenzyme Q10

Design: randomised controlled trial
Species: human
Population: women with polycystic ovary syndrome (PCOS), aged 18-40 years
Participants: not recorded
Comparator: not stated in the paper
Duration: 84 days
Endpoints: 9
Record: extracted
Readings recorded: 2